Clinical Trial Update: Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

View source ↗

Summary

A single-arm exploratory trial evaluating the combination of apatinib and capecitabine as second-line therapy for advanced gastric cancer, with endpoints includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• Capecitabine (capecitabine)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety | Status: UNKNOWN